Hi!

Y'all have probably read enough critiques of this stinker:

   Exposure DraftCommunications Legislation Amendment (Combatting
   Misinformation and Disinformation) Bill 2023
   
<https://www.infrastructure.gov.au/department/media/publications/communications-legislation-amendment-combatting-misinformation-and-disinformation-bill-2023>

but if you want to read mine, it is at:

   https://www.firstpr.com.au/issues/


My big page of links to and discussion of the immune system's need for at least 125 nmol/L 25 ng/mL circulating 25-hydroxyvitamin D (as measured in "vitamin D" blood tests):

   https://vitamindstopscovid.info/00-evi/

There is an article https://brownstone.org/articles/vitamin-d-everything-you-need-to-know/ which covers much of this, and has a cheerful robotic voice version, if you want to listen to it.  However, my primary aim is to encourage people to read the research themselves, rather than accept what I write.

For most 70 kg (154 lb) people who are not suffering from obesity, a daily (on average, it can be taken once every 7 to 10 days) intake of vitamin D2 cholecalciferol of 0.125 mg (5000 IU) will generally attain, after several months,  125 nmol/L 25 ng/mL circulating 25-hydroxyvitamin D, which is 1 part in 20,000,000 by mass.

"Five thousand international units" sounds like a lot, but it is 1/8 of a milligram.  Per day, this is a gram every 22 years. Pharma grade vitamin D3 costs about USD$2.50 a gram.

Less than 125 nmol/L circulating 25-hydroxyvitamin D raises risks of a plethora of diseases and chronic conditions, including Parkinson's disease and most or all of the other age-related neurodegenerative conditions.   I am trying to be brief.  This may sound too simple to be true, but please read the research for yourself.

I also have a Substack: https://nutritionmatters.substack.com.


   Best regards

     Robin                      Daylesford, Victoria.




_______________________________________________
Link mailing list
[email protected]
https://mailman.anu.edu.au/mailman/listinfo/link

Reply via email to